Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.07 Down 0.09(0.64%) 3:59PM EDT
|After Hours : 14.28 Up 0.21 (1.49%) 6:52PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 416   620   980   97  
Cost of Revenue -   -   -   -  
Gross Profit 416   620   980   97  
Operating Expenses
Research Development27,070  17,804  20,417  15,090  
Selling General and Administrative4,582  4,677  3,579  3,411  
Non Recurring -   -   -   -  
Others253  253  253  254  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (31,489) (22,114) (23,269) (18,658)
Income from Continuing Operations
Total Other Income/Expenses Net1,586  137  142  161  
Earnings Before Interest And Taxes(29,903)(21,977)(23,127)(18,497)
Interest Expense -  85  13  519  
Income Before Tax(29,903)(22,062)(23,140)(19,016)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(29,903)(22,062)(23,140)(19,016)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (29,903) (22,062) (23,140) (19,016)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (29,903) (22,062) (23,140) (19,016)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.